PBPHOverviewHoldingsDividends
Fund holdings · Portfolio Building Block World Pharma and Biotech Index ETF

PBPH holdings: all 53 positions

PBPH held 53 positions as of Jul 31, 2026. Eli Lilly & Co is the largest at 15.20%; the top 10 are 61.9% of the fund.

Share
Download CSVPBPH fund page
How much of the fund each position is · one bar per position, largest first
LLY 15.20%53 positionsIONS 0.18%
61.9%
top 10 together
15.20%
largest position
33
positions under 1%

Every position

53 of 53 · click a column to sort
PBPH’s 53 positions by weight, from the holdings filed for Jul 31, 2026. A weight is a share of net assets. Source: Form N-PORT filed with the SEC.
#HoldingTickerWeight ↓
1Eli Lilly & CoLLY15.20%
2Johnson & JohnsonJNJ9.66%
3AbbVie IncABBV6.94%
4Merck & Co IncMRK5.04%
5Roche Holding AGROP4.74%
6Amgen IncAMGN4.63%
7Novartis AGNOVN4.47%
8Astrazeneca PLCAZN3.90%
9Gilead Sciences IncGILD3.77%
10Novo Nordisk A/SNOVOB3.51%
11Pfizer IncPFE3.33%
12Bristol-Myers Squibb CoBMY3.11%
13Vertex Pharmaceuticals IncVRTX2.82%
14GSK PLCGSK2.26%
15Sanofi SASAN2.17%
16Regeneron Pharmaceuticals IncREGN1.79%
17Bayer AGBAYN1.27%
18Takeda Pharmaceutical Company Ltd45021.25%
19Argenx SEARGX1.24%
20CSL LtdCSL1.11%
21Teva Pharmaceutical Industries LtdTEVA0.96%
22Natera IncNTRA0.85%
23Sandoz Group AGSDZ0.78%
24Revolution Medicines IncRVMD0.77%
25Zoetis IncZTS0.76%
26Illumina IncILMN0.72%
27UCB SAUCB0.72%
28Biogen IncBIIB0.70%
29Otsuka Holdings Company Ltd45780.67%
30Chugai Pharmaceutical Co Ltd45190.64%
31Haleon PLCHLN0.64%
32Alnylam Pharmaceuticals IncALNY0.63%
33Daiichi Sankyo Company Ltd45680.62%
34Incyte CorpINCY0.56%
35Astellas Pharma Inc45030.56%
36United Therapeutics CorpUTHR0.51%
37Royalty Pharma PLCRPRX0.51%
38Merck KgaaMRK0.50%
39Insmed IncINSM0.48%
40Viatris IncVTRS0.47%
41Moderna IncMRNA0.45%
42Genmab A/SGMAB0.40%
43Neurocrine Biosciences IncNBIX0.39%
44Roivant Sciences LtdROIV0.38%
45Jazz Pharmaceuticals PLCJAZZ0.36%
46Elanco Animal Health IncELAN0.31%
47Roche Holding AGRO0.31%
48Shionogi & Co. Ltd45070.31%
49Exelixis IncEXEL0.30%
50Bridgebio Pharma IncBBIO0.27%
51Galderma Group AGGALD0.27%
52BioMarin Pharmaceutical IncBMRN0.27%
53Ionis Pharmaceuticals IncIONS0.18%
Cash and other net assets0.55%
As of Jul 31, 2026. Source: Form N-PORT filed with the SEC.

The book

FundPortfolio Building Block World Pharma and Biotech Index ETF
Positions53
Holdings as of (SEC N-PORT)Jul 31, 2026
SourceForm N-PORT filed with the SEC ↗
Top 10 together61.9%
Cash and other net assets0.55%

By country

United States64.9%
Switzerland10.6%
United Kingdom7.3%
Japan4.0%
Denmark3.9%
France2.2%
Other6.5%

Share of the fund, positions only, as the fund’s SEC filing states them.

By asset type

Stocks94.7%
Preferred stocks4.7%

Share of the fund, positions only, as the fund’s SEC filing states them.

What this list is

How the list is built

Each weight is the share of net assets the fund’s SEC filing gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.

Weights are as the source states them, largest first.

Where to next
PBPH fund page→Overlap of PBPH with another fund→Which ETFs hold a company→Compare two funds→How books are read→
Where these figures came from
Form N-PORT filed with the SEC ↗SEC Form N-PORT, what a fund filed it holds ↗SEC EDGAR, full-text search of fund filings ↗

ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →

Cite this pageCitation, APA and Markdown

ETFIQ, Holdings of PBPH, data as of Jul 31, 2026. https://etfiq.com/funds/pbph/holdings/

Open data →

Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.